证券代码：300962 证券简称：中金辐照 公告编号：2025-116 中金辐照股份有限公司 第四届董事会第二十五次会议决议的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整， 没有虚假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 经全体董事一致同意豁免本次董事会会议通知期限要求，中金辐照 股份有限公司（以下简称公司）于 2025 年 12 月 25 日在公司总部会议 室以现场结合通讯方式召开了第四届董事会第二十五次会议。本次会议 应参加表决董事 7 名，实际参加表决董事 7 名。公司高级管理人员列席 会议，会议由公司董事长方中华先生主持。会议的召集、召开和表决程 序符合法律、法规及《公司章程》的规定。 二、董事会会议审议情况 与会董事对本次会议需审议的议案进行了充分讨论，审议通过了以 下议案： （一）审议通过《关于向控股子公司提供财务资助的议案》。 经审议，董事会同意公司在不影响自身正常业务开展及资金使用的 情况下，向成都公司提供额度不超过人民币 7,300 万元的借款，额度范 围内可循环使用。同时公司董事会授权公司经理层办理与本次财务资助 相关的协议签署、款项支付等事宜。具体内容详见 ...

证券代码：300962 证券简称：中金辐照 公告编号：2025-115 根据《中华人民共和国公司法》《深圳证券交易所上市公司自律监 管指引第 2 号——创业板上市公司规范运作》及《公司章程》等相关规 定，鲍海文先生的辞职报告自送达董事会之日起生效。截至本公告日， 鲍海文先生不存在应当履行而未履行的承诺事项。鲍海文先生的辞职不 会影响公司相关工作的正常开展。 鲍海文先生在担任公司董事期间恪尽职守、勤勉尽责，在推动公司 规范运作和健康发展方面发挥了积极作用，公司及董事会对鲍海文先生 为公司发展所作的贡献表示衷心感谢！ 特此公告。 中金辐照股份有限公司董事会 中金辐照股份有限公司 关于董事离任的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整， 没有虚假记载、误导性陈述或重大遗漏。 中金辐照股份有限公司（以下简称公司）董事会于近日收到公司董 事鲍海文先生递交的书面辞职报告。因工作调整原因，鲍海文先生申请 辞去公司第四届董事会董事、董事会战略委员会委员职务。鲍海文先生 原任职期限至公司第四届董事会任期届满之日（2026 年 9 月 15 日）。 辞职后，鲍海文先生将不再担任公司任何职务。 2025 年 ...

Group 1 - The signing ceremony for the electronic accelerator intelligent manufacturing project investment agreement took place on December 17, with the participation of the management from Zhongjin Irradiation Co., Ltd. and the government of Sanhe City, Hebei Province [1][3] - The electronic accelerator intelligent manufacturing project is a key initiative for Zhongjin Irradiation to enhance its core functions and competitiveness, and it represents a significant step for China Gold Group in fostering new productive forces [3] - The project aligns with the industrial development direction of Sanhe City, and the local government expressed its commitment to optimizing the business environment and supporting the project's construction and enterprise development [3] Group 2 - Zhongjin Irradiation aims to leverage its advantages in industry, capital, talent, and management to establish a multi-level and wide-ranging cooperation framework with Hebei Province and local governments, contributing to the high-quality economic development of the region [3] - The local government officials acknowledged the project's high technological content and strong industrial driving force, emphasizing its compatibility with the regional development strategy [3]

Core Insights - The company, Zhongjin Fuzhao (300962), reported that as of November 28, 2025, the number of shareholders (merged) is 17,357 accounts according to information obtained from China Securities Depository and Clearing Corporation Limited [1] Summary by Categories - **Shareholder Information** - The total number of shareholders for Zhongjin Fuzhao is 17,357 accounts as of the specified date [1]

一、本次搬迁补偿事项概述 中金辐照股份有限公司（以下简称公司）子公司深圳市金鹏源辐 照技术有限公司（以下简称深圳金鹏源）为配合深圳市光明区光明街 道白花片区连片产业用地土地整备工作，于 2025 年 4 月 3 日与光明 街道办、深业明瑞签署了《搬迁补偿安置协议》及《补充协议》，具 体内容详见公司于 2025 年 4 月 7 日披露的《中金辐照股份有限公司 关于子公司签署搬迁补偿安置协议及补充协议的进展公告》（公告编 号：2025-010）。 证券代码：300962 证券简称：中金辐照 公告编号：2025-114 中金辐照股份有限公司关于子公司收到 搬迁补偿款的进展公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完 整，没有虚假记载、误导性陈述或重大遗漏。 公司及深圳金鹏源将持续加强与协议相关方沟通，敦促其履行合 同义务，尽快支付剩余搬迁补偿款项。 公司董事会将密切关注搬迁补偿事项进展情况，按照中国证监会 《上市公司信息披露管理办法》《深圳证券交易所创业板股票上市规 则》等相关法规要求，及时履行信息披露义务。 特此公告。 中金辐照股份有限公司董事会 2025 年 12 月 12 日 二、收到搬迁补偿 ...

Group 1 - The core point of the article highlights that the number of shareholders for Zhongjin Fuzhao decreased to 16,259 as of December 10, representing a decline of 1,098 shareholders or 6.33% compared to the previous period [2] - The closing price of Zhongjin Fuzhao was reported at 16.54 yuan, remaining flat, with a cumulative decline of 9.47% in stock price since the concentration of shares began, showing 3 days of increase and 6 days of decrease [2] - The company's third-quarter report indicates that it achieved a total operating revenue of 278 million yuan, reflecting a year-on-year growth of 2.33%, while net profit was 89.81 million yuan, a decrease of 6.35% year-on-year, with basic earnings per share at 0.3402 yuan and a weighted average return on equity of 9.20% [2]

Group 1 - The national standard for sterilization radiation of medical products has been officially released, which will take effect on January 1, 2029 [2] - This standard aims to regulate the development, confirmation, and routine control of sterilization processes for medical devices, providing clear guidance for the industry [2] - The implementation of this standard is expected to enhance the reliability and effectiveness of sterilization processes, ensuring that products meet the required sterility standards throughout their shelf life [2] Group 2 - Zhongjin Irradiation Co., Ltd. is a high-tech enterprise under China National Gold Group, specializing in the application of irradiation technology [2] - The company has extensive experience in the industry and has participated in the formulation of 19 national and industry standards related to irradiation sterilization for healthcare products, food, and sterile packaging materials [2]

Market Overview - The professional services sector experienced a decline of 0.59% on December 2, with Zhongjin Radiation leading the drop [1] - The Shanghai Composite Index closed at 3897.71, down 0.42%, while the Shenzhen Component Index closed at 13056.7, down 0.68% [1] Stock Performance - Notable gainers in the professional services sector included: - Xince Standard (300938) with a closing price of 35.45, up 3.20% and a trading volume of 124,200 shares, totaling 430 million yuan [1] - Lansiqimi (300795) closed at 15.90, up 2.19% with a trading volume of 112,800 shares, totaling 178 million yuan [1] - Conversely, significant decliners included: - Zhongquanfuzhao (300962) with a closing price of 17.99, down 4.56% and a trading volume of 107,800 shares, totaling 25.66 million yuan [2] - Anbang Guard (603373) closed at 41.24, down 2.80% with a trading volume of 6,815 shares, totaling 28.42 million yuan [2] Capital Flow - The professional services sector saw a net outflow of 132 million yuan from institutional investors, while retail investors experienced a net inflow of 89.54 million yuan [2] - The detailed capital flow for selected stocks showed: - Xince Standard (300938) had a net inflow of 30.20 million yuan from institutional investors, while retail investors had a net outflow of 16.85 million yuan [3] - Huace Testing (300012) recorded a net inflow of 6.18 million yuan from institutional investors, with a net outflow of 7.52 million yuan from retail investors [3]

Core Viewpoint - Zhongjin Irradiation (300962.SZ) announced a plan to issue A-shares to specific investors, aiming to raise up to RMB 800 million for various sterilization projects and working capital [1][2]. Group 1: Fundraising Details - The total amount to be raised is capped at RMB 80,000,000, which will be used for projects including the Changsha Sterilization Technology Service Center and the Hefei Comprehensive Sterilization Technology Center [1]. - The issuance will target no more than 35 specific investors, including China National Gold Group, which will subscribe RMB 10,000,000 worth of shares [1]. - The number of shares issued will not exceed 30% of the total share capital prior to the issuance, amounting to a maximum of 79,200,569 shares [1]. Group 2: Pricing and Financial Performance - The issuance will adopt a bidding method, with the price set at no less than 80% of the average trading price over the 20 trading days prior to the pricing date or the higher of the latest audited net asset value per share [2]. - For the first three quarters of 2025, Zhongjin Irradiation reported revenue of RMB 278 million, a year-on-year increase of 2.33%, while net profit attributable to shareholders decreased by 6.35% to RMB 89.81 million [2]. - The net profit excluding non-recurring gains and losses was RMB 78.99 million, down 15.35% year-on-year, with net cash flow from operating activities at RMB 130 million [2].

Core Viewpoint - The company, Zhongjin Ruzhao, plans to raise up to 800 million yuan through a private placement to fund several sterilization technology projects and supplement working capital, with the controlling shareholder, China National Gold Group, participating in the investment [1][2]. Group 1: Fundraising and Investment Projects - Zhongjin Ruzhao intends to issue shares to no more than 35 specific investors, including China National Gold Group, to raise funds for projects including the Changsha Sterilization Technology Service Center and the Hefei Comprehensive Sterilization Technology Center [1][2]. - The total investment for the Changsha and Hefei projects is 400 million yuan, with planned fundraising allocations of 100 million yuan and 200 million yuan respectively, yielding after-tax internal rates of return of 11.35% and 8.51% [2]. - The company also plans to invest 100 million yuan in the second phase of the annual sterilization medical device project at Zhongjin Health Technology (Jiaxing), which has a total investment of 108 million yuan [2]. Group 2: Operational Strategy and Market Position - The company has established a national presence with service areas including Shenzhen, Shanghai, Tianjin, Qingdao, Wuhan, Chengdu, Chongqing, and Jiaxing, aiming to enhance regional connectivity and market share through the new projects [3]. - Zhongjin Ruzhao's main business segments include irradiation technology services, disinfection supply services, and technical testing services, with irradiation technology being the primary source of revenue and profit [3]. - The company has formed long-term strategic partnerships with over 30 Fortune 500 companies, serving various industries such as healthcare, food, pharmaceuticals, daily necessities, and packaging materials [3]. Group 3: Financial Performance - For the first three quarters of 2025, Zhongjin Ruzhao reported revenues of 278 million yuan and a net profit of 89.81 million yuan, reflecting a year-on-year decline of 6.35% [4].